Significantly, mouse subcutaneous CRC xenograft model showed that CHD6 KD (Dox-inducible CHD6 KD) showed a lower tumor burden (Fig. 1d; Supplementary Fig. S4a, b). This evidence concerns the gene CHD6 and neoplasm.